Related Experiment Videos
Simultaneous pancreas-kidney and pancreas transplantation
B N Becker1, Y T Becker, J S Odorico
1Division of Nephrology, Department of Medicine, University of Wisconsin, 2500 Overlook Terrace, Madison, WI 53705, USA. bnb@medicine.wisc.edu
Summary
Pancreas transplantation, including simultaneous pancreas-kidney (SPK) and pancreas transplantation alone (PTA), offers significant benefits for type 1 diabetes mellitus (DM). This procedure can improve survival, manage complications, and enhance quality of life.
Area of Science:
- Transplantation immunology
- Endocrinology
- Nephrology
Background:
- Type 1 diabetes mellitus (DM) management remains challenging, with whole pancreas transplantation being the most effective method for achieving normoglycemia.
- Pancreas transplantation, encompassing simultaneous pancreas-kidney (SPK) and pancreas transplantation alone (PTA), has evolved beyond metabolic control to address DM complications and improve lifespan.
- Despite advancements, recipients face post-transplant complications, including cardiovascular disease and hypertension, alongside procedure-specific risks.
Purpose of the Study:
- To evaluate the therapeutic advancements and benefits of pancreas transplantation for type 1 DM.
- To highlight the improved outcomes and viability of SPK and PTA transplants due to surgical and immunosuppression advancements.
- To underscore pancreas transplantation as a viable treatment for improving survival and quality of life in type 1 DM patients, particularly those with kidney disease.
Main Methods:
- Review of current practices and outcomes in pancreas transplantation (SPK and PTA).
- Analysis of improvements in surgical techniques and immunosuppressive therapies.
- Assessment of patient selection criteria and post-transplant complication management.
Main Results:
- Pancreas transplantation effectively reverses metabolic abnormalities and minimizes complications associated with type 1 DM.
- SPK and PTA transplants are increasingly viable and functional long-term, enhancing patient survival and quality of life.
- Recipients, while insulin-independent, require management for common post-transplant issues and procedure-specific complications.
Conclusions:
- Pancreas transplantation represents a significant therapeutic advance for type 1 DM, offering improved survival and reduced complication burden.
- Enhanced surgical and immunosuppressive strategies have made SPK and PTA transplantation more successful and long-term functional.
- This procedure is particularly beneficial for type 1 DM patients with co-existing kidney disease, improving overall health outcomes.